Ignite Creation Date:
2025-12-25 @ 2:52 AM
Ignite Modification Date:
2026-03-03 @ 2:58 PM
Study NCT ID:
NCT02349633
Status:
TERMINATED
Last Update Posted:
2021-06-10
First Post:
2015-01-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study For Patients With NSCLC EGFR Mutations (Del 19 or L858R +/- T790M)
Sponsor:
Pfizer
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
B7971001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None